CD274 and neoplasm: In vivo and in vitro experiments of prostate cancer revealed that coadministration of oncolytic adenovirus expressing PD-L1 mini-antibody and CAR-T cells effectively promoted effector cell proliferation, resulting in enhanced anti-tumor efficacy and extended tumor-bearing mice survival.